Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 19, 2000
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma
S Perea, G J Pennick, A Modak, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1997
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants
M Hidalgo, J Hornedo, C Lumbreras, et al.
The Journal of Antimicrobial Chemotherapy
|
February 28, 2002
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
M Martínez, J L López-Ribot, W R Kirkpatrick, et al.
The Open Neurology Journal
|
May 27, 2014
Study of a Functional Polymorphism in the PER3 Gene and Diurnal Preference in a Colombian Sample
Claudia S Perea, Carmen L Niño, Sandra López-León, et al.
Journal of Biological Rhythms
|
January 15, 2021
Lunar Cycle Influences Reproductive Performance of Crossbred Brahman Cows Under Tropical Conditions
Alejandro A Aguirre, Roberto A Palomares, Aitor D De Ondiz, et al.
Cancer
|
January 28, 1999
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial
M Hidalgo, J Hornedo, C Lumbreras, et al.
The Journal of Antimicrobial Chemotherapy
|
August 25, 1999
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis
S Perea, M Hidalgo, A Arcediano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2000
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial
C Gomez-Martin, C Solá, J Hornedo, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea, J L López-Ribot, W R Kirkpatrick, et al.
Neuroscience Letters
|
August 24, 2013
A novel association of two non-synonymous polymorphisms in PER2 and PER3 genes with specific diurnal preference subscales
Diego A Ojeda, Claudia S Perea, Carmen L Niño, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
April 19, 2000
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma
S Perea, G J Pennick, A Modak, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1997
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants
M Hidalgo, J Hornedo, C Lumbreras, et al.
The Journal of Antimicrobial Chemotherapy
|
February 28, 2002
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
M Martínez, J L López-Ribot, W R Kirkpatrick, et al.
The Open Neurology Journal
|
May 27, 2014
Study of a Functional Polymorphism in the PER3 Gene and Diurnal Preference in a Colombian Sample
Claudia S Perea, Carmen L Niño, Sandra López-León, et al.
Journal of Biological Rhythms
|
January 15, 2021
Lunar Cycle Influences Reproductive Performance of Crossbred Brahman Cows Under Tropical Conditions
Alejandro A Aguirre, Roberto A Palomares, Aitor D De Ondiz, et al.
Cancer
|
January 28, 1999
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial
M Hidalgo, J Hornedo, C Lumbreras, et al.
The Journal of Antimicrobial Chemotherapy
|
August 25, 1999
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis
S Perea, M Hidalgo, A Arcediano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2000
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial
C Gomez-Martin, C Solá, J Hornedo, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea, J L López-Ribot, W R Kirkpatrick, et al.
Neuroscience Letters
|
August 24, 2013
A novel association of two non-synonymous polymorphisms in PER2 and PER3 genes with specific diurnal preference subscales
Diego A Ojeda, Claudia S Perea, Carmen L Niño, et al.
Page
of 4